150 related articles for article (PubMed ID: 15258046)
1. New treatments for colon cancer.
Slevin M; Payne S
BMJ; 2004 Jul; 329(7458):124-6. PubMed ID: 15258046
[No Abstract] [Full Text] [Related]
2. Optimizing oxaliplatin-based therapy in metastatic colorectal cancer.
Cassidy J
Clin Adv Hematol Oncol; 2008 May; 6(5):360-1. PubMed ID: 18516025
[No Abstract] [Full Text] [Related]
3. NCCN guideline updates: colon and rectal cancers, version 1.2004.
National Comprehensive Cancer Network
J Natl Compr Canc Netw; 2004 Jul; 2(4):284-5. PubMed ID: 19795595
[No Abstract] [Full Text] [Related]
4. Accrual delayed in adjuvant bevacizumab trial.
Tuma RS
J Natl Cancer Inst; 2006 Apr; 98(7):439-40. PubMed ID: 16595779
[No Abstract] [Full Text] [Related]
5. [Adjuvant therapy for colon cancer].
Lordick F; Rosenberg R; Stein HJ; Peschel C; Siewert JR
Dtsch Med Wochenschr; 2004 Oct; 129(44):2366-71. PubMed ID: 15497107
[No Abstract] [Full Text] [Related]
6. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin (Eloxatin) for advanced colon cancer.
Med Lett Drugs Ther; 2003 Jan; 45(1148):7-8. PubMed ID: 12571541
[No Abstract] [Full Text] [Related]
8. Current stages of adjuvant treatment of colon cancer.
Köhne CH
Ann Oncol; 2012 Sep; 23 Suppl 10():x71-6. PubMed ID: 22987996
[No Abstract] [Full Text] [Related]
9. [Successes in late solid tumors. New therapy offer].
Arnheim K
MMW Fortschr Med; 2004 Nov; 146(47):71. PubMed ID: 15624667
[No Abstract] [Full Text] [Related]
10. [Chemotherapy of colonic cancer].
Block S
Soins; 2010 Mar; (743):46. PubMed ID: 20423037
[No Abstract] [Full Text] [Related]
11. Phase III trial of FOLFOX plus bevacizumab or cediranib (AZD2171) as first-line treatment of patients with metastatic colorectal cancer: HORIZON III.
Robertson JD; Botwood NA; Rothenberg ML; Schmoll HJ
Clin Colorectal Cancer; 2009 Jan; 8(1):59-60. PubMed ID: 19203899
[TBL] [Abstract][Full Text] [Related]
12. Targeted agents for adjuvant therapy of colon cancer.
Saif MW
Clin Colorectal Cancer; 2006 May; 6(1):46-51. PubMed ID: 16796791
[TBL] [Abstract][Full Text] [Related]
13. Advances in adjuvant chemotherapy for colon cancer.
Nelson H
Minerva Chir; 1992 Mar; 47(5):213-22. PubMed ID: 1594115
[No Abstract] [Full Text] [Related]
14. Adjuvant therapy for colorectal cancer: yesterday, today, and tomorrow.
Beaven AW; Goldberg RM
Oncology (Williston Park); 2006 Apr; 20(5):461-9; discussion 469-70, 473-5. PubMed ID: 16739745
[TBL] [Abstract][Full Text] [Related]
15. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
Malik Z; Eng C
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
[No Abstract] [Full Text] [Related]
16. Overstated conclusions of a pooled analysis of bevacizumab in colon cancer.
Goffin JR; Talavera JR
J Clin Oncol; 2006 Jan; 24(3):528-9; author reply 529-30. PubMed ID: 16421433
[No Abstract] [Full Text] [Related]
17. [Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection].
Zhang SZ
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):801-3. PubMed ID: 21223682
[No Abstract] [Full Text] [Related]
18. Leucovorin-induced hypersensitivity reaction.
Damaske A; Ma N; Williams R
J Oncol Pharm Pract; 2012 Mar; 18(1):136-9. PubMed ID: 21248170
[TBL] [Abstract][Full Text] [Related]
19. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
Grothey A; Sargent DJ
J Clin Oncol; 2005 May; 23(15):3311-3. PubMed ID: 15908645
[No Abstract] [Full Text] [Related]
20. Phase III multicenter randomized clinical trial to evaluate the safety and efficacy of CoFactor/5-fluorouracil/bevacizumab versus leucovorin/5-fluorouracil/bevacizumab as initial treatment for metastatic colorectal carcinoma.
Saif MW; Merritt J; Robbins J; Stewart J; Schupp J
Clin Colorectal Cancer; 2006 Sep; 6(3):229-34. PubMed ID: 17026795
[No Abstract] [Full Text] [Related]
[Next] [New Search]